Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6WYA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,868
Award facts
- Contract value 100% obligated
- $25,868.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $25,868.10, is for the delivery of 120 capsules of the drug Xtandi 40 mg, a specialized medication used in the treatment of prostate cancer. The contract has an ultimate completion date of December 27, 2024.
DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products.
This contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Quick answers
Who was awarded contract SPE2DX25F6WYA?
SPE2DX25F6WYA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 26, 2024.
How much is contract SPE2DX25F6WYA worth?
The government has obligated $25,868 on SPE2DX25F6WYA.
Is contract SPE2DX25F6WYA an order under another contract?
Yes. SPE2DX25F6WYA is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6WYA competed?
The extent of competition for SPE2DX25F6WYA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award